Mesa Laboratories keeps USD 0.16 dividend for Mesa Laboratories stock

Published on 10/20/2026 at 19:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q1 2027 revenue reached USD 60.14 million on June 30, 2026. Mesa Laboratories stock costs EUR 114.00 on October 20, 2026 at 6:59 p.m. CEST.

Dividend and reporting dates

Mesa Laboratories kept its quarterly dividend at USD 0.16 on October 9, 2026.
First-quarter fiscal 2027 revenue reached USD 60.14 million for the period ended June 30, 2026.
Mesa Laboratories stock costs EUR 114.00 at Lang & Schwarz on October 20, 2026 at 6:59 p.m. CEST.
Mesa Laboratories is estimated to report second-quarter fiscal 2027 results on November 5, 2026.

MLAB, US59064R1095, Illustration mit AI erstellt.

Mesa Laboratories kept its quarterly dividend at USD 0.16 per share on October 9, 2026, while Mesa Laboratories stock stood at EUR 114.00 at Lang & Schwarz on October 20, 2026 at 6:59 p.m. CEST. MarketScreener reported that the dividend is payable on December 15, 2026 to shareholders of record on November 30, 2026.

Revenue reached USD 60.14 million

Mesa Laboratories reported USD 60.14 million in revenue and USD 2.68 in earnings per share for the first quarter of fiscal 2027 ended June 30, 2026. The company recorded USD 2.83 million in net income for that period. MarketBeat also reported the quarterly revenue and earnings figures on October 5, 2026.

Specialized products support demand

Mesa Labs develops and sells life sciences tools and quality control products for regulated markets. Its portfolio covers sterilization and disinfection control, clinical genomics, biopharmaceutical development and calibration solutions, according to Mesa Laboratories. The business model links product demand to pharmaceutical, healthcare and laboratory compliance requirements.

What comes next for results?

Mesa Laboratories is estimated to report second-quarter fiscal 2027 results on November 5, 2026, after the market closes. The same calendar lists a conference call for November 9, 2026 at 4:00 p.m. ET, with consensus estimates of USD 62.20 million in revenue and USD 2.29 in earnings per share. MarketBeat identifies November 5 as the announcement date.

Stock value and company scale

Mesa Laboratories had a market capitalization of USD 715.8 million and reported 28,894 shares of volume in the latest structured market snapshot dated October 20, 2026. The company profile lists 717 full-time employees and places its headquarters in Lakewood, Colorado. For investors, the next reported quarter will test whether revenue can move above the USD 60.14 million first-quarter level while the USD 0.16 dividend remains the immediate cash-return feature.

Price stays at EUR 114.00

Mesa Laboratories stock was trading at EUR 114.00 at Lang & Schwarz on October 20, 2026 at 6:59 p.m. CEST. The quote was in the after-hours phase for the German market.

The further course of trading is shown by the continuously updated real-time quote of Mesa Laboratories stock.